Privium Fund Management (UK)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,108
Closed -$2.06M 109
2022
Q2
$2.06M Buy
+14,108
New +$2.06M 2.33% 12